REQUEST A DEMO
Total
USD $0.00
Search more companies

New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: New Ray Medicine International Holding Limited Profile Updated: February 03, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) is an enterprise in Hong Kong SAR, China, with the main office in Hong Kong. The company operates in the Pharmaceutical and Medicine Manufacturing industry. New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) was incorporated on April 01, 2026. There are currently 29 (2024) people employed by New Ray Medicine International Holding Limited (新锐医药国际控股有限公司). In Q2C2025, the company reported a net sales revenue increase of 167.38%. Its’ total assets recorded a negative growth of 9.68%. The net profit margin of New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) increased by 7.77% in 2025.

Headquarters
Room 911B, 9Th Floor, Tower 1, Silvercord
Hong Kong; Hong Kong;

Contact Details: Purchase the New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) report to view the information.

Website: http://www.newraymedicine.com

Basic Information
Total Employees:
Purchase the New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) report to view the information.
Outstanding Shares:
Purchase the New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) report to view the information.
Registered Capital:
Purchase the New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) report to view the information.
Financial Auditors:
Purchase the New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) report to view the information.
Incorporation Date:
April 01, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
25.52%
Purchase this report to view the information.
9.65%
Purchase this report to view the information.
9.65%
Purchase this report to view the information.
7.16%
Purchase this report to view the information.
Subsidiaries
Max Goodrich International Limited (United Kingdom)
100%
Major Bright Holdings Limited (United Kingdom)
Company Performance
Financial values in the chart are available after New Ray Medicine International Holding Limited (新锐医药国际控股有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
167.38%
Total Operating Revenue
166.73%
Operating Profit
-69.47%
EBITDA
-184.72%
Net Profit/Loss for the Period
-82.34%
Total Assets
-9.68%
Total Equity
-9.45%
Operating Profit Margin
9.49%
Net Profit Margin
7.77%
Return on Equity (ROE)
-0.89%
Debt / Equity
475%
Quick Ratio
1216.28%
Cash Ratio
-0.97%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?